Interaction of the oncogene protein myc with specific DNA fragments

Insights

The p110gag-myc protein binds preferentially to cellular DNA flanking the MC29 retrovirus integration site. This finding refutes the autoregulatory model of viral gene expression.

Area of Science:

  • Molecular Biology
  • Retroviral Research
  • Protein-DNA Interactions

Background:

  • The MC29 retrovirus encodes the p110gag-myc protein, a potential regulator of viral gene expression.
  • Previous hypotheses suggested an autoregulatory model where the protein binds to the viral LTR promoter/enhancer region.

Purpose of the Study:

  • To investigate the DNA-binding properties of the purified p110gag-myc protein.
  • To determine if the protein interacts with viral or cellular DNA sequences.

Main Methods:

  • Purification of p110gag-myc protein using immuno-affinity chromatography.
  • Filter binding assays to study protein-DNA interactions with fragments from a MC29 DNA clone.
  • Agarose gel electrophoresis to analyze DNA fragments retained by the protein.

Main Results:

  • The p110gag-myc protein was purified 3,000-fold.
  • Preferential binding of the protein to a DNA fragment from flanking cellular sequences was observed.
  • No preferential binding to the viral LTR promoter/enhancer region was detected.

Conclusions:

  • The p110gag-myc protein interacts with flanking cellular DNA, not the viral LTR.
  • The autoregulatory model for MC29 retrovirus gene expression is not substantiated by these findings.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...